Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-09-21 8:24 pm Purchase | 2026-09-14 | 13G | X4 PHARMACEUTICALS INC XFOR | Venrock Healthcare Capital Partners III, L.P. | 5,555,047 5.600% | 5,555,047 (New Position) | Filing History |
| 2026-09-15 4:56 pm Purchase | 2026-09-08 | 13D | CYCLERION THERAPEUTICS INC CYCN | Venrock Healthcare Capital Partners III, L.P. | 4,552,277 9.900% | 4,552,277 (New Position) | Filing History |
| 2026-09-08 5:08 pm Sale | 2026-09-03 | 13D | APOGEE THERAPEUTICS INC APGE | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | -3,887,478 (Position Closed) | Filing History |
| 2026-08-14 4:55 pm Purchase | 2026-06-30 | 13G | VOR BIOPHARMA INC VOR | Venrock Healthcare Capital Partners III, L.P. | 5,676,370 9.900% | 592,493 (+11.65%) | Filing History |
| 2026-08-14 4:54 pm Sale | 2026-06-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Venrock Healthcare Capital Partners III, L.P. | 1,574,892 4.700% | -380,213 (-19.45%) | Filing History |
| 2026-08-14 4:53 pm Sale | 2026-06-30 | 13G | ORUKA THERAPEUTICS INC ORKA | Venrock Healthcare Capital Partners III, L.P. | 4,556,952 7.400% | -352,667 (-7.18%) | Filing History |
| 2026-08-14 4:51 pm Sale | 2026-06-30 | 13G | APPLIED THERAPEUTICS INC APLT | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | -5,567,709 (Position Closed) | Filing History |
| 2026-08-14 4:50 pm Purchase | 2026-06-30 | 13G | JADE BIOSCIENCES, INC. JBIO | Venrock Healthcare Capital Partners III, L.P. | 5,145,330 8.300% | 29,468 (+0.58%) | Filing History |
| 2026-08-14 4:49 pm Sale | 2026-06-30 | 13G | ENGENE HLDGS INC ENGN | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | -4,771,414 (Position Closed) | Filing History |
| 2026-08-14 4:49 pm Purchase | 2026-06-30 | 13G | ARTIVA BIOTHERAPEUTICS INC ARTV | Venrock Healthcare Capital Partners III, L.P. | 2,043,596 4.200% | 434,027 (+26.97%) | Filing History |
| 2026-08-14 4:48 pm Unchanged | 2026-06-30 | 13G | ADLAI NORTYE GROUP LTD. AMERIC ANL | Venrock Healthcare Capital Partners III, L.P. | 9,638,193 4.400% | 0 (Unchanged) | Filing History |
| 2026-06-09 8:03 pm Purchase | 2026-06-02 | 13G | RELMADA THERAPEUTICS INC P RLMD | Venrock Healthcare Capital Partners III, L.P. | 6,508,433 6.200% | 6,508,433 (New Position) | Filing History |
| 2026-05-15 4:36 pm Sale | 2026-03-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | Venrock Healthcare Capital Partners III, L.P. | 9,982,124 4.600% | -5,579,376 (-35.85%) | Filing History |
| 2026-05-15 4:35 pm Sale | 2026-03-31 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Venrock Healthcare Capital Partners III, L.P. | 1,726,331 2.800% | -1,500,000 (-46.49%) | Filing History |
| 2026-05-15 4:34 pm Purchase | 2026-03-31 | 13G | ERASCA INC ERAS | Venrock Healthcare Capital Partners III, L.P. | 16,382,812 5.300% | 166,596 (+1.03%) | Filing History |
| 2026-05-15 4:33 pm Sale | 2026-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | Venrock Healthcare Capital Partners III, L.P. | 4,319,765 4.200% | -1,356,465 (-23.90%) | Filing History |
| 2026-05-15 4:32 pm Purchase | 2026-03-31 | 13G | SURROZEN INC SRZN | Venrock Healthcare Capital Partners III, L.P. | 1,205,000 9.900% | 332,454 (+38.10%) | Filing History |
| 2026-05-15 4:31 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Venrock Healthcare Capital Partners III, L.P. | 1,955,105 9.900% | 1,262,146 (+182.14%) | Filing History |
| 2026-05-15 4:30 pm Purchase | 2026-03-31 | 13G | VOR BIOPHARMA INC VOR | Venrock Healthcare Capital Partners III, L.P. | 5,083,877 9.900% | 2,867,802 (+129.41%) | Filing History |
| 2026-05-15 4:29 pm Purchase | 2026-03-31 | 13G | ZURA BIO LTD ZURA | Venrock Healthcare Capital Partners III, L.P. | 9,816,384 9.900% | 3,463,031 (+54.51%) | Filing History |